Cite
HARVARD Citation
Bilger, G. et al. (2022). Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study. Therapeutic advances in medical oncology. p. . [Online].